Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

8304	Companies
115199	Keywords
55516	Articles
62566	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 06/20/2024 at 01:10, 5 months 2 days ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends financing agreement with Atlas, ensures funding for clinical programs OBA in obesity and MYODA in DMD. Details on the contract amendment and risk factors

Biophytis Atlas Financing Agreement Clinical Programs Risk Factors
PRESS RELEASE

published on 06/20/2024 at 01:10, 5 months 2 days ago

Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités. Renouvellement de l'accord de financement obligataire pour le lancement de programmes cliniques OBA et MYODA

Contrat Biophytis Financement Atlas OBA
BRIEF

published on 06/19/2024 at 23:05, 5 months 2 days ago

Biophytis prolonge son contrat avec Atlas pour le financement de ses activités

Biophytis Biotechnologie Financement ORNANE Atlas
BRIEF

published on 06/19/2024 at 23:05, 5 months 2 days ago

Biophytis Extends Financing Contract with Atlas

Biophytis Biotechnology Financing Clinical Trials Atlas
REGULATED PRESS RELEASE

published on 06/19/2024 at 23:00, 5 months 2 days ago

Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
Biophytis renouvelle son accord de financement avec Atlas pour sécuriser ses activités. La société émettra des obligations convertibles pour un montant maximum de 16 millions d'euros

Biophytis Financement Obligations Convertibles Atlas Programmes Cliniques
REGULATED PRESS RELEASE

published on 06/19/2024 at 23:00, 5 months 2 days ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends bond financing agreement with Atlas, securing funding for clinical programs in obesity and Duchenne Muscular Dystrophy. Terms reflect confidence in growth potential

Biophytis Atlas Growth Potential Clinical Programs Bond Financing Agreement
BRIEF

published on 06/12/2024 at 10:16, 5 months 10 days ago

Biophytis announces the success of the industrial transfer of production of BIO101

Biophytis Biotechnology Duchenne Muscular Dystrophy BIO101 Seqens
BRIEF

published on 06/12/2024 at 10:16, 5 months 10 days ago

Biophytis annonce le succès du transfert industriel de production de BIO101

Biophytis Biotechnologie Dystrophie Musculaire De Duchenne BIO101 Seqens
PRESS RELEASE

published on 06/12/2024 at 10:11, 5 months 10 days ago

Biophytis annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens
Biophytis annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens. La société se focalise sur le traitement de maladies liées à l'âge, notamment la Dystrophie Musculaire de Duchenne

Biophytis BIO101 Seqens Transfert Industriel DMD
PRESS RELEASE

published on 06/12/2024 at 10:11, 5 months 10 days ago

Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens
Biophytis successfully transfers BIO101 (20-hydroxyecdysone) production to industrial scale with Seqens, enhancing therapeutic solutions for Duchenne Muscular Dystrophy patients

Biophytis Duchenne Muscular Dystrophy BIO101 Seqens 20-hydroxyecdysone

Accesswire

Published on 11/22/2024 at 09:00, 2 hours 13 minutes ago

Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 11 hours 13 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 13 hours 8 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 13 hours 23 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 14 hours 58 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 11:06, 6 minutes ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/22/2024 at 11:00, 12 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 10:46, 26 minutes ago

Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 09:45, 1 hour 27 minutes ago

The GSMA – China Unicom Open Gateway Global Use Case Innovation Challenge has begun!
Published on 11/22/2024 at 09:23, 1 hour 49 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding issuance of subordinated notes

Les Echos

Published on 11/21/2024 at 06:58, 1 day 4 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 4 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 4 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 15 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 15 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE